Bomin Kim

Private Equity Sponsor Transactions

• Ettain group, a portfolio company of A&M Capital Partners, in its add-on acquisition of Bradford & Galt, an IT staffing and consulting firm.
• Brightstar Capital Partners in its acquisition of Engineering Research and Consulting, Inc., a provider of mission critical engineering and consulting services to the U.S. Department of Defense, NASA and other high-tech governmental entities.
• EQT Infrastructure in its $5.3 billion acquisition of Covanta, an owner and operator of waste-to-energy facilities in North America.
• Kinderhook Industries in its acquisition of Live Oak Environmental, a regional provider of solid waste hauling services for residential, commercial and industrial waste generators.
• L Catterton in its acquisition of majority stake in HGGC-backed Beauty Industry Group (BIG), a provider of professionally-installed and DIY hair extension products.
• Carlyle Group in its majority stake acquisition in Beautycounter, the leader in clean beauty products, accelerating its strategic initiatives and increasing brand awareness
• Vestar Capital Partners in its majority investment in PetHonesty, a provider of premium pet health products.
• Warburg Pincus in its $150 million Series E financing of Aura (f/k/a Intersections), a digital security provider.

Public Company Representations

• Allergan Aesthetics, an AbbVie company, in its pending $550 million acquisition of Soliton, a medical technology company focused on developing and commercializing products utilizing its proprietary designed acoustic shockwave technology platform referred to as RAP

IP Litigation

• Representing Microspherix in patent litigation involving Merck’s implantable contraceptive Nexplanon (etonogestrel implant); successfully defended client’s patent estate in inter partes review proceedings before the USPTO.
• Represented Red Hat, IBM, and their customers in defensive action against patent assertion entity on a patent related to storage management. Achieved favorable claim construction that forced patentee to stipulate to non-infringement.
• Represented Teva in an ANDA case against Merck concerning the drug alvimopan (Entereg®).
• Represented Abbott Cardiovascular, successfully defending against five inter partes review petitions filed by Edwards Lifesciences challenging Abbott’s patents covering MitraClip®, resulting in denial of all five petitions.
• Represented Samsung Electronics against WiNet Labs LLC (S.D.N.Y.) in its defense of a patent infringement action related to ad-hoc network methods.

Summer Associate, Kirkland & Ellis LLP

Summer Associate, Baker Botts LLP